The short version
- In a 2001 crossover trial in 30 adults over 50, a 0.3mg melatonin dose restored sleep efficiency and normalised plasma melatonin, while 3.0mg induced hypothermia and left melatonin elevated into daylight hours.
- A systematic review of 16 studies in adults over 55 concluded that the lowest possible immediate-release melatonin dose best mimics the normal circadian rhythm and avoids prolonged supra-physiological blood levels.
- A meta-analysis of 19 trials in 1,683 people found melatonin cut time to fall asleep by 7.06 minutes and increased total sleep time by 8.25 minutes — statistically significant but small.
- The American Academy of Sleep Medicine's 2017 guideline suggests clinicians not use melatonin for sleep onset or sleep maintenance insomnia, a weak recommendation based on 2mg trials with very low quality evidence.
- Analysis of 31 melatonin supplements found content ranging from 83% below to 478% above the label, with more than 71% missing their label claim by over 10%.
Walk the sleep aisle and the numbers climb: 3mg, 5mg, 10mg, occasionally 20mg. Now find the trial that compared doses against each other in the same people. The dose that came out best was 0.3mg.
The study that actually varied the dose
Zhdanova and colleagues published it in the Journal of Clinical Endocrinology and Metabolism in 2001. Thirty people over 50 — 15 who slept normally and 15 with actigraphically confirmed reductions in sleep efficiency — each received placebo and three melatonin doses, 0.1mg, 0.3mg and 3.0mg, in randomised order, taken 30 minutes before bed for a week at a time with week-long washouts between. Sleep was measured by polysomnography on the last three nights of each period.
The physiological dose, 0.3mg, restored sleep efficiency (P < 0.0001), acting principally in the middle third of the night, and raised plasma melatonin into the normal nocturnal range. The pharmacological dose, 3.0mg, also improved sleep — but it induced hypothermia and left plasma melatonin elevated into the daylight hours.
And here is the detail that reframes the whole category: the good sleepers, who also had low melatonin levels, did not improve at any dose. Melatonin is not a sedative you can push harder for a bigger effect. In this trial it restored something in people whose signal had degraded, and did nothing at all in people whose sleep was already fine.
Why "still circulating at 9am" is the part to care about
Vural and colleagues reviewed 16 studies, nine of them randomised, on melatonin dosing in adults over 55, at doses ranging from 0.1mg upward. Blood levels rose in a dose-dependent way, and higher doses kept levels above threshold for longer. Their recommendation is unusually direct for a systematic review: use the lowest possible dose of an immediate-release formulation, to best mimic the normal physiological circadian rhythm and to avoid prolonged, supra-physiological blood levels.
Melatonin's job is to tell your body it is night. A dose still in circulation the next morning is delivering that message at the wrong time.
The part that argues against us
We are not going to give you only the half that suits the argument. Ferracioli-Oda and colleagues pooled 19 studies and 1,683 subjects in PLoS One in 2013. Melatonin reduced time to fall asleep by 7.06 minutes (95% CI 4.37 to 9.75), increased total sleep time by 8.25 minutes (95% CI 1.74 to 14.75), and improved sleep quality with a standardised mean difference of 0.22. All statistically significant. All small.
And in their meta-regression, trials with longer duration and higher doses showed greater effects on sleep latency and total sleep time. That cuts directly against a clean low-dose story, and it belongs in this article.
The reconciliation, as best we can offer it: the meta-analysis measured how fast and how long. The dose-comparison trial measured sleep efficiency and where in the night the effect landed. Those are different questions with different answers, and the case for low doses is a physiological argument rather than a unanimous one.
What the sleep physicians say
The American Academy of Sleep Medicine's 2017 clinical practice guideline on pharmacologic treatment of chronic insomnia works through individual drugs one at a time. Recommendation 12 reads: clinicians should not use melatonin as a treatment for sleep onset or sleep maintenance insomnia versus no treatment in adults.
The context matters as much as the recommendation. It is graded WEAK. It rests on trials of 2mg doses, all in adults over 55, and the task force rated the overall quality of that evidence very low. They also noted, drily, that patients are likely to take melatonin anyway given its availability and its reputation as benign. This is not a warning. It is a guideline saying the evidence is not there yet at the doses that were studied.
The number on the label may not be the number in the capsule
Erland and Saxena analysed 31 commercial melatonin supplements by liquid chromatography for a 2017 paper in the Journal of Clinical Sleep Medicine. Melatonin content ranged from 83% below to 478% above the labelled amount. Lot-to-lot variability within a single product reached 465%. More than 71% of products missed their label claim by more than 10%. Serotonin — a controlled substance in some jurisdictions — was found in eight of them, at 1 to 75 µg.
So "I took 3mg" is a statement about a label, not about a dose. Third-party batch testing is the only reason to believe the number, and it is a fair thing to demand of any brand, us included.
What we'd actually tell you
On our own shelf: REST+ contains melatonin alongside magnesium and botanicals. UNWIND is melatonin-free by design. We are deliberately not quoting you a milligram figure here — read the supplement facts panel on the product page itself, and if the number is higher than you want after reading this, take less of it or take the melatonin-free one. Both are tools. Neither is a sedative and we will not sell them to you as one.
If you do use melatonin: start at the low end rather than the shelf default, take it at the same clock time every night rather than whenever you feel tired, and judge it over two weeks rather than one bad Tuesday. Persistent sleep problems belong with a clinician — there is a long list of things that disrupt sleep, and most of them are not a melatonin deficiency.
Good questions
Is 10mg of melatonin too much?
It is far more than the trials suggest you need, and probably counterproductive. The one study that compared doses head to head found 0.3mg restored sleep efficiency, while 3mg caused hypothermia and left melatonin circulating into the next morning. A systematic review in older adults recommended the lowest possible immediate-release dose. Nothing in that literature supports 10mg as a starting point.
Does melatonin actually knock you out?
No, and expecting that is why people escalate the dose. Melatonin is a hormonal timing signal, not a sedative. In a meta-analysis of 19 trials, it cut sleep onset by about seven minutes on average. In the dose-comparison trial, people who already slept well got no benefit at any dose. If you want to be knocked out, melatonin is the wrong product.
Can I take melatonin every night long term?
The trials are mostly short, so nobody can honestly promise you long-term safety data. What is known is that higher doses keep blood levels elevated well beyond the night, which is not what the hormone normally does. If you are taking it nightly for months without improvement, that is a signal to talk to a clinician about what is actually disrupting your sleep.
Why do sleep doctors seem lukewarm on melatonin?
Because the trial evidence is thin at the doses studied. The American Academy of Sleep Medicine's 2017 guideline suggests clinicians not use melatonin for sleep onset or maintenance insomnia. That recommendation is graded weak, is based on 2mg trials in adults over 55, and the evidence quality was rated very low. It reflects an evidence gap rather than a safety alarm.
Am I actually getting the dose on the label?
Often not. When researchers analysed 31 commercial melatonin products, content ranged from 83% below to 478% above the label claim, batch-to-batch variation within one product reached 465%, and serotonin turned up in eight of them. More than 71% missed their label by over 10%. Third-party batch testing is the only reason to trust the number, on any brand.
Do LUVO's sleep products contain melatonin?
One does and one does not. REST+ includes melatonin alongside magnesium and botanicals; UNWIND is melatonin-free by design. We are not quoting a milligram figure in an article, because the supplement facts panel on each product page is the authoritative place for it. If the number is higher than you want after reading this, take less or choose the melatonin-free formula.
Sources
- Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab, 2001. View study
- Vural EM, van Munster BC, de Rooij SE. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. Drugs Aging, 2014. View study
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One, 2013. View study
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med, 2017. View study
- Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med, 2017. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
